EGFR and cancer: As shown in Table 3 and Table 4, univariate analysis revealed that there was a significant correlation between the incidences of irAEs and EGFR-TKI therapy history (p = 0.025), ICI cycles (p = 0.009), cancer types (p = 0.009) and Eos (p < 0.037).